Small molecules & peptides
DOTA-Lanreotide acetate
Precursor for radiolabelled DOTA-Lanreotide
DOTA-BIM-23014; CA index name: L-Threoninamide, 3-(2-naphthalenyl)-N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7) disulfide
Sequence: DOTA-D-2Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH₂, cyclic disulfide; DOTA = N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-; Supplied as acetate salt
Quality
Research Chemical
Characteristics
Molar mass 1481.7
CAS RN [213187-44-1] (net peptide)
Purity ≥ 95 %
- Colorless to off-white freeze-dried solid
Certificates
CoA: appearance, MS (identity), HPLC (purity)
Literature
Smith-Jones P.M. et al. DOTA-Lanreotide: a novel somatostatin analog for tumor diagnosis and therapy. Endocrinology 1999, 140, 5136 - 5148.
Banerjee S. et al. ¹⁷⁷Lu-DOTA-lanreotide: a novel tracer as a targeted agent for tumor therapy. Nucl. Med. Biol. 2004, 31, 753–759.
Add to inquiry
| Product | Product No. | Filling amount | Quantity | ||
|---|---|---|---|---|---|
| /products/small-molecules-and-peptides/chemical/cd7249bf-5285-41ec-8aa9-827b081091f0 | Chemicals | Product No.: 9831 | Filling amount: 1 mg | ||
| /products/small-molecules-and-peptides/chemical/cd7249bf-5285-41ec-8aa9-827b081091f0 | Chemicals | Product No.: 9831 | Filling amount: 10 mg | ||
| /products/small-molecules-and-peptides/chemical/cd7249bf-5285-41ec-8aa9-827b081091f0 | Chemicals | Product No.: 9831 |
Product was added